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Abstract 
Up to 40% of ischemic strokes have no known cause (cryptogenic). The prevalence of 
persistent foramen ovale (PFO) amongst patients with cryptogenic stroke (CS) is twice as 
high as that of the normal population, therefore suggesting a causal relationship 
between the two entities. However, PFO by itself is not sufficient to cause stroke, as an 
embolic source is needed. This source is often unknown, making the causal relationship 
between CS and PFO hard to demonstrate. The most frequent, although still seldom, 
identifiable cause of embolism in an otherwise cryptogenic stroke associated with PFO is 
a deep venous thrombosis (DVT) of the lower extremities. Here, we present a unique case 
of brachiocephalic venous DVT associated with PFO and ischemic stroke in a young 
patient. As the search for DVT in patients with PFO and stroke is often limited to the 
lower extremities, this case may suggest that an unspecified number of DVTs are 
overlooked. Our report lends support to paradoxical embolism as a mechanism of stroke 
in patients with PFO and does, at least in selected cases, suggest a more detailed search 
for DVT beyond the lower extremities. 
 
Introduction 
We report the unique case of a patient with brachiocephalic deep venous thrombosis 
(DVT) and persistent foramen ovale (PFO) who developed ischemic stroke in the absence 
of other risk factors for stroke. This may suggest the need for more detailed search for the 
embolic source in selected cases. Case Rep Neurol 2011;3:160–164 
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A large percentage of ischemic strokes have no known cause (up to 40%) [1, 2]. PFO 
prevalence amongst cases of cryptogenic stroke (CS) is twice as high as that of the normal 
population [3], making a causal relationship possible. Stroke mechanism in this setting is 
thought to be a paradoxical embolism arising from a venous or right atrial source. The 
embolic source is, however, only seldom found [4], possibly because the search for 
thrombotic episodes is often restricted to the lower extremities, which makes up for only 
approximately one third of the embolic sources in clinically plausible cases of paradoxical 
embolism and stroke [5]. In our patient, the thrombus was detected using brachiocephalic 
venography done during PFO closure. 
Case Report 
A 40-year-old mildly overweight female Caucasian without a history of seizures or risk factors for 
atherosclerosis and DVT was referred to us for further evaluation 4 weeks after an acute-onset right-
sided sensorimotor hemiparesis, dizziness and mild mnestic dysfunction. The symptoms purportedly 
persisted for about 12 h (NIH stroke scale of approx. 4) and disappeared over a period of 24 h without 
sequelae. She had a similar, but much shorter and milder episode affecting the left extremities several 
weeks earlier, which had been attributed to a migraine, but may also have been a transient ischemic 
attack (TIA). On examination, no pathological findings were detected (NIH stroke scale = 0). In 
particular, heart murmurs and lower limb swellings were absent. Blood pressure and blood glucose on 
admission were 125/65 mm Hg and 105 mg/dl, respectively. Blood pressure monitoring during 
admission showed normal values. 
Magnetic resonance imaging revealed a left-sided, wedge-shaped lesion in the inferotemporal cortex 
(fig. 1a), clearly suggesting recent ischemia due to occlusion of a temporal branch of the posterior 
cerebral artery. There was neither cerebral hemorrhage nor evidence of atherosclerosis of the brain 
arteries. Laboratory tests including cholesterol and coagulation parameters (proteins C and S, 
antithrombin III, prothrombin mutation and antiphospholipid antibodies) revealed no pathological 
findings. Cerebrospinal fluid analysis showed no evidence of cerebral inflammation. 24-hour Holter 
ECG showed no evidence of atrial fibrillation. Interestingly, transesophageal contrast-enhanced 
echocardiography (TEE + Contrast) revealed a significant PFO (fig. 1b) with spontaneous right-to-left 
shunt and a hypermobile interatrial septum with a maximum deviation of 8 mm towards the right 
atrium, but no evidence of intracardiac thrombus or aortic plaques. Duplex ultrasound of the lower 
extremities revealed no evidence of DVT. 
The guidelines recommend acetylsalicylic acid 100–300 mg for first time CS in the setting of PFO 
and warfarin after a recurrence. The possible episode of TIA several weeks earlier made the current case, 
affecting a different territory as the former, a recurrence which made us initiate therapy with a vitamin 
K antagonist (phenprocoumon) to reach an INR between 2.0 and 3.0 as a bridge to PFO closure since 
the patient could not be convinced to stay on this therapy for 2 or more years as suggested in the 
guidelines. Twelve weeks later, an interventional fluoroscopic and TEE-guided PFO closure using an 
Amplatzer 25-mm device was carried out, which necessitated a dual antiplatelet therapy for 6 months. 
During this procedure an angiography of the brachiocephalic vein revealed residue of a venous wall 
adherent thrombus (fig. 1c). Anticoagulation was discontinued because the thrombus was deemed to be 
old and well organized. Follow-up at 3 months was uneventful. A detailed history and physical 
examination followed by a plain chest X-ray in 2 plains, an abdominal ultrasound and a gynecological 
examination including mammography revealed no findings in support of malignancy as a possible cause 
of the unusually located DVT. 
Discussion 
PFO as a conduit for paradoxical embolism causing stroke is debated, despite the 
existence of extensive epidemiological evidence suggesting a causal relationship between 
PFO and CS [3, 6–8]. The prevalence of PFO among young ischemic stroke patients is Case Rep Neurol 2011;3:160–164 
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twice as high as that of the normal population (25%) [3]. However, PFO alone cannot 
represent the direct etiology of a stroke, as it always requires the presence of a thrombotic 
source. Here, we hypothesized paradoxical embolism as a plausible cause of the ischemic 
event. Paradoxical embolism is easily demonstrable on contrast echocardiography in the 
presence of PFO and there have been cases of transit thrombus literally ‘caught in the act’ 
of crossing the interatrial septum via a PFO [9]. Nevertheless, large trials (including the 
more recent CLOSURE I trial) have not proven PFO closure to be superior to other forms 
of therapy, such as aspirin and warfarin, in preventing recurrent CS. These studies have, 
however, enrolled a heterogeneous group of patients (those in which the PFO is possibly 
just an epiphenomenon and those with a strong evidence of paradoxical embolism) [10] 
coupled with the development of multiple possible causes (left atrial clot, atrial 
fibrillation, etc.) of recurrent stroke in the course of a trial, undermining the 
conclusiveness of the data interpretation. This latter reason, coupled with the fact that 
nearly 30,000 young patients yearly have a CS and PFO, may suggest to rethink future 
trial strategies [11], for example PFO closure plus best medical therapy versus best 
medical therapy alone. However, the uniqueness in our case is the occurrence of an 
inferotemporal cortex stroke following a possible TIA several weeks earlier in association 
with PFO in the presence of an extremely rare DVT location. This strongly suggests 
paradoxical embolism as the cause of the ischemic insult, especially in the absence of a 
cardioembolic source and atherosclerotic risk factors. 
Stroke is a potentially debilitating disease with a high propensity to recur, especially in 
the absence of adequate therapy. Therefore, patients with DVT and a higher probability of 
paradoxical embolism as in the case of coexisting PFO with right-to-left shunt and stroke 
should, even in the absence of inherited coagulation disorders, be treated with vitamin K 
antagonist for an average period of 6 months (in keeping with DVT guidelines), followed 
by PFO closure. Critics rightly propose that underlying DVT is only seldom found in 
patients with ischemic stroke and PFO. However, this may also be due to the dissolution 
of the source of embolism at the time of the diagnostic investigation, the heterogeneous 
expertise of the sonographers or the search for such culprit DVT being limited to the 
lower extremities. In addition, studies on pulmonary embolism (PE) have shown a DVT 
prevalence of only 18% and of 36–45% in patients with suspected and with confirmed PE, 
respectively [12], suggesting that DVT is a frequent cause of embolism, and that the 
presence of PFO in these patients may be a risk factor for stroke. Furthermore, Otten et al. 
[13] demonstrated the existence of DVT in unusual locations in patients admitted to 
hospital for other reasons, suggesting that other venous sources of emboli are often 
overlooked. Brachiocephalic DVT is a rare entity (<0.06% of hospitalized patients), 
associated with central venous catheters, Crohn’s disease and occult malignancy 
(Trousseau’s syndrome) [13–15]. A search beyond the lower limbs may become, however, 
necessary in case of recurrent cryptogenic stroke, especially when an embolic pattern and 
one or the other risk factor (e.g. central venous line, inflammatory bowel disease, 
malignancy, etc.) for upper limb DVT are evident. 
To our knowledge, this is the first reported case of brachiocephalic DVT associated with 
ischemic stroke and PFO. This suggests that in selected cases such as in young patients with 
stroke of embolic pattern, prior central venous catheter and history of Crohn’s disease or 
malignancy, further examination of the venous system beyond the lower extremities may be 
warranted. With the exclusion of cases where the thrombus has already dissolved at the 
time of examination, this would further strengthen the evidence for paradoxical embolism. Case Rep Neurol 2011;3:160–164 
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Fig. 1. a cMRT FLAIR sequence showing a 2.5 × 1.4-cm wedge-shaped, left-sided hyperintense lesion in 
the inferotemporal cortex (arrows), clearly suggesting a recent ischemia due to occlusion of a temporal 
branch of the posterior cerebral artery. b Contrast TEE demonstrates PFO – a clear separation of the 
membranes of the interatrial septum (asterisk) between contrasted right atrium (RA) and contrast-free 
left atrium (LA). c Thoracic fluoroscopy with left brachiocephalic venography demonstrates a 2.5 × 1.5-
cm, wedge-shaped, superior wall adherent, radio-opaque structure, clearly suggesting a brachiocephalic 
vein thrombus (white arrow and black asterisk). 
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